Yifeng Reconciled Depreciation from 2010 to 2024
| 603939 Stock | 22.56 1.40 5.84% |
Reconciled Depreciation | First Reported 2010-12-31 | Previous Quarter 1.6 B | Current Value 1.7 B | Quarterly Volatility 669.5 M |
Check Yifeng Pharmacy financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Yifeng Pharmacy's main balance sheet or income statement drivers, such as Interest Expense of 168.6 M, Selling General Administrative of 5.9 B or Total Revenue of 23.7 B, as well as many indicators such as . Yifeng financial statements analysis is a perfect complement when working with Yifeng Pharmacy Valuation or Volatility modules.
Yifeng | Reconciled Depreciation |
Currently Active Assets on Macroaxis
Other Information on Investing in Yifeng Stock
Yifeng Pharmacy financial ratios help investors to determine whether Yifeng Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Yifeng with respect to the benefits of owning Yifeng Pharmacy security.